Hygieia said today that it won 510(k) clearance from the FDA for its insulin management app designed to optimize insulin dosing among people with Type 2 diabetes. The Michigan-based company touted its product as the first insulin management mobile app that can titrate individualized doses for all types of insulin regimens. Get the full story at […]
Diabetes healthcare company Hygieia’s d-Nav Diabetes Insulin Guidance System (DIGS) won CE Mark approval in the European Union for treatment of patients with poor glycemic control.
DIGS automatically updates insulin dosage as needed, providing users with the updates at-time rather than requiring a clinical visit. A pair of U.K. diabetes centers plan to start using d-Nav this fall, and an Irish hospital will begin a 6-month service evaluation of the technology, according to a press release.